|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Fixed maturities, at fair value (amortized cost: 2026—$20,411; 2025—$18,304) | ||||||||||||||||||||
| Fair Value, Inputs, Level 1 | ||||||||||||||||||||
| Total fixed maturities, at fair value (amortized cost: 2026—$20,411; 2025—$18,304) | ||||||||||||||||||||
| Equity securities, at fair value (cost: 2026—$4,273; 2025—$4,155) | ||||||||||||||||||||
| Short-term investments, at fair value (amortized cost: 2026—$144; 2025—$148) | ||||||||||||||||||||
| Fair Value, Inputs, Level 1 | ||||||||||||||||||||
| Total short-term investments, at fair value (amortized cost: 2026—$144; 2025—$148) | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Investment income receivable | ||||||||||||||||||||
| Finance receivable | ||||||||||||||||||||
| Premiums receivable | ||||||||||||||||||||
| Reinsurance recoverable | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Land, building and equipment, net, for company use (accumulated depreciation: 2026—$381; 2025—$367) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Separate accounts | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Insurance reserves | ||||||||||||||||||||
| Loss and loss expense reserves | ||||||||||||||||||||
| Reserve for loss and loss expenses | ||||||||||||||||||||
| Life policy and investment contract reserves | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Deferred income tax | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Long-term debt and lease obligations | ||||||||||||||||||||
| Separate accounts | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, par value—$2 per share; (authorized: 2026 and 2025—500 million shares; issued: 2026 and 2025—198.3 million shares) | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock at cost (2026—44.8 million shares and 2025—42.9 million shares) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
